Ads have been rolled out for free users and those on the 399 rupee ($4) per month 'Go' plan.

The Defense Department had barred the U.S. military from using Anthropic's Claude in March

High-Flyer Quant, which bankrolled DeepSeek, has come to the fore, making a push into new listings as it chases returns in China's red-hot IPO market.

U.S. and Chinese officials met in Beijing this week, despite the White House's tough talk on China.

CrowdStrike CEO said Thursday that AI is allowing attackers to find and exploit vulnerabilities faster, making the company's protection a must.

CNBC’s Jim Cramer said strong earnings from Nvidia and Salesforce shattered two major bear cases that had weighed on the tech stocks.

The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.

These are the stocks posting the largest moves in after-hours trading.

World Liberty’s proposed trust bank has preliminary federal approval as the Trump-backed crypto venture deepens its ties to a senior UAE official.

The fight over AI and its associated data center infrastructure has spilled into election-after-election this year.

Prior Fed chairs have used the speech as an opportunity to lay out broad policy frameworks and intentions.

At the groundbreaking ceremony for SK Hynix's first U.S. facility, CEO Kwak Noh-Jung says Indiana will be a key memory production base by 2030.

The Model Hardware Standard is initially available in a research preview, but Anthropic plans to open source it in the future.

The letter also urged a coordinated government effort to make cyber defense accessible to critical infrastructure under pressure.

These are some of the stocks posting the largest moves midday.

Jim Cramer shares why there more momentum behind CrowdStrike's stellar performance this year

Salesforce reported a strong beat on second-quarter earnings and announced an expanded AI partnership with Anthropic.

CNBC's Jim Cramer said the demand for Nvidia's chips is accelerating because customers are finding they can make money from the technology almost immediately.

Nvidia is optimizing hardware for DeepSeek and Qwen while warning that potential U.S. restrictions on models originating in China could hurt its business.

AI adoption is pushing customers to spend more on cybersecurity tools from companies such as CrowdStrike and Okta

Here are five key things investors need to know to start the trading day.

The policymaker stopped just short of calling for an interest rate hike.

These are the stocks posting the largest moves premarket.

Meta's agreement to settle a federal social media addiction case with state AGs doesn't absolve the company of similar litigation or potential regulation.

Nvidia shares rose on Thursday after the chip giant's revenue guidance reassured investors that AI demand will remain strong.

Nvidia reportedly agreed to buy open source AI platform Hugging Face for $12.9 billion as the chipmaker expands deeper into the AI ecosystem.

The Chinese AI company said it had already launched the model globally in stealth mode for a week.

Nvidia CEO Jensen Huang did it again.

These are the stocks posting the largest moves in after-hour trading.

These are some of the stocks posting the largest moves in midday trading.

The South Korean automaker wants to keep going by ramping up production at a new $7.6 billion plant in Georgia to capture more sales and market share.

These are the stocks posting the largest moves premarket.

Short dramas' model posits a new alternative to traditional entertainment models, but distribution poses rising cost and audience retention challenges.

It's a sign of adoption of Huawei technology outside China, despite the U.S. restricting the company from working with American suppliers such as Google.

HHS plans to name two deputy commissioners for technology and drugs, said two sources familiar with the matter.

These are the stocks posting the largest moves midday.

The U.S. can pressure Chinese banks over Iran through access to its financial system, while Beijing is building alternatives such as CIPS.

These are the stocks posting the largest moves in early trading.

Bugatti CEO Mate Rimac told CNBC he thinks high-end sports cars will continue to have combustion engines "for a very long time" even with the rise of EVs.

Indian IT services giant TCS has secured a $1.5 billion contract to deploy AI for German sports carmaker Porsche.

Speculators still see yields hitting new highs in 2026 and ending the year at levels elevated from where they're currently trading.

Goldman Sachs is embracing AI, but one of its senior tech leaders warns that it comes with an unintended risk: weakening the reasoning skills of future bankers.

The bigger issue at hand may be that many Americans fall into a large, uncertain middle ground – neither firmly pro-vaccine nor staunchly opposed.

BioMarin will acquire Alesta Therapeutics for $275 million upfront, bolstering BioMarin's unit focused on rare skeletal conditions.

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTC's lawsuit against the company, compounded GLP-1 drugs and AI.

Nome uses AI and drug-development expertise to help rare disease families turn genetic diagnoses into potential paths toward treatment.

A U.S. appeals court has ruled in favor of Gilead Sciences against companies known as alternative funding programs that import medicines from overseas.

Novo Nordisk CEO defended the company's decision to sue rival Eli Lilly over its weight-loss drug advertising.

Federal dollars in the two health insurance programs would not go toward gender-affirming care, but states could still cover the treatments.

The quarter wasn't totally clean, but strong profitability matters the most.

Doctors and other experts say that splitting the measles, mumps and rubella shot has no scientific basis and is unlikely to get off the ground.

Jazz Pharmaceuticals will acquire Actio Biosciences, Inc., a deal that expands Jazz's pipeline and presence in rare epilepsy treatments.

Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.

The order builds on the Trump administration's efforts to reshape the childhood shot schedule under HHS Secretary RFK Jr., a longtime a vaccine skeptic.

Genetic testing is helping doctors identify rare diseases earlier, opening the door to treatment options before symptoms appear.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

"The cancer has spread, is metastasized into his bones and further. It's very painful. It's very debilitating in many respects," Hunter Biden said.

Traffic to salad chains has fallen as consumers avoid greens due to the ongoing cyclospora outbreaks across the U.S.

"On the advice of my doctors, I'll maintain an intensive regimen of physical therapy from home during the state work period," the 84-year-old McConnell said.